Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Invested Capital (2016 - 2025)

Cumberland Pharmaceuticals' Invested Capital history spans 16 years, with the latest figure at $24.9 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 10.99% year-over-year to $24.9 million; the TTM value through Dec 2025 reached $24.9 million, down 10.99%, while the annual FY2025 figure was $24.9 million, 10.99% down from the prior year.
  • Invested Capital for Q4 2025 was $24.9 million at Cumberland Pharmaceuticals, down from $26.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $47.8 million in Q2 2021 and bottomed at $24.9 million in Q4 2025.
  • The 5-year median for Invested Capital is $36.0 million (2022), against an average of $35.1 million.
  • The largest annual shift saw Invested Capital dropped 29.33% in 2024 before it grew 6.33% in 2025.
  • A 5-year view of Invested Capital shows it stood at $42.6 million in 2021, then decreased by 15.56% to $36.0 million in 2022, then dropped by 0.89% to $35.7 million in 2023, then dropped by 21.6% to $28.0 million in 2024, then dropped by 10.99% to $24.9 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Invested Capital are $24.9 million (Q4 2025), $26.1 million (Q3 2025), and $27.7 million (Q2 2025).